ABCA1 and Stroke: These data indicate that ABCA1 deficit decreases myelination in the IBZ of WM, while HDL3 or ApoE2 treatment attenuates ABCA1-B/-B-induced deficits in the myelination of WM, which may contribute to the neurological functional improvement after stroke.